Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David R. Freyer, DO, MS
Children's Hospital Los Angeles
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
76 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Children'S and Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Saskatoon Cancer Centre at the University of Saskatchewan
Saskatoon, Saskatchewan, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Canada
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Childrens Hospital Los Angeles
Los Angeles, California, United States
- Southern California Permanente Medical Group
Los Angeles, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Alfred I. Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lee Cancer Care of Lee Memorial Health System
Fort Myers, Florida, United States
- Nemours Children'S Clinic
Jacksonville, Florida, United States
- University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida, United States
- Florida Hospital Cancer Institute at Florida Hospital Orlando
Orlando, Florida, United States
- Nemours Children'S Clinic - Orlando
Orlando, Florida, United States
- Nemours Children'S Clinic - Pensacola
Pensacola, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- St. Joseph'S Cancer Institute at St. Joseph'S Hospital
Tampa, Florida, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Mountain States Tumor Institute at St. Luke'S Regional Medical Center
Boise, Idaho, United States
- University of Illinois Cancer Center
Chicago, Illinois, United States
- Saint Jude Midwest Affiliate
Peoria, Illinois, United States
- Riley'S Children Cancer Center at Riley Hospital for Children
Indianapolis, Indiana, United States
- Blank Children'S Hospital
Des Moines, Iowa, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Kosair Children'S Hospital
Louisville, Kentucky, United States
- Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, United States
- Children'S Hospital of New Orleans
New Orleans, Louisiana, United States
- National Naval Medical Center
Bethesda, Maryland, United States
- C.S. Mott Children'S Hospital at University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jun 2008
- Primary completion
- 9 Apr 2015
- Completion
- 30 Jun 2021
- Last update posted
- 9 Nov 2023
- Registered enrollment
- 131
- Registry id
- NCT00716976
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.